Skip to content

DETOX PHARMA

Active Risk: not assessed
Private limited companyfounded 2019active for 7 yearsBoulevard de l'Hôpital 61, 7800 Ath, BelgiumKBO/BCE: BE 0722.889.827
Summary

DETOX PHARMA has a registered holding activity and consists mainly of financial fixed assets. The bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €107,406 and a net result of €152,406. Equity has been shrinking by about 6.4% per year since 2019. Its solvency ranks better than 12% of 10,818 sector peers (NACE 70, financial year 2025). The company has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Official details

Source: KBO
Status
Active since 19-03-2019 Normal situation
Activity
Business and other management consultancy NACE 70200and 1 other
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2022
Establishment unit
2.287.873.969 7850 Enghien, since 19-03-2019
Financial year end
31 December
Peppol
Reachable since 20-05-2025

Board and ownership

Board
  • Cannuyer ChristopheDirector
  • Moneta DelphineDirector

Financial position

Holding: outside the score modelBankruptcy probability: sector outside the model
Annual accounts 2025
Gross margin
€125,207
▼ 2.3%
Turnover
≈ €200,000
estimated
Profit
€152,406
▲ 77.5%
Equity
€107,406
▼ 37.8%
Total assets
€1.9m
=
SignalsneutralLatest accounts filed on timeShow the evidence

Checked score

Outside the general model
Holding: general score not applicable
The company has a registered holding activity. Financial fixed assets make up more than half of its assets. The general model for operating companies does not fit such a balance sheet, so there is no score and no financial strength.
Bankruptcy probability within 12 months

The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
31 days early
2024
20 days late
2023
21 days late
2022
31 days early
2021
18 days early
2020
46 days early
2019
37 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 17 days before the deadline. In the sector (NACE 70), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 July (4 of the last 5 accounts filed within 38 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Result rose in 2025from €85,869 to €152,406 ▲ 77.5% View
  • Caution: Lower solvency than 87% of companies in head offices and management consultancysector median 52.4% · 10,818 companies 5.6% View
  • Positive: 7 profitable years in a rowprofit 2025: €152,406 7 years View

Recent changes

  1. · Gazette deed Registered office moved from Enghien to AthNew seat: Boulevard de l'Hôpital 61, 7800 ATH · Previous seat: Rue de Sambre 12-14-7850 Enghien
  2. · Gazette deed Incorporation
All 11 events

Comparable companies

These companies have the same main activity as DETOX PHARMA: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €1.7m and €2m, founded between 2018 and 2019.

CompanyTotal assetsGross margin
DETOX PHARMA Ath€1.9m€0.1m
GENEROEK Antwerpen€1.7m€0.1m
AFAR INVEST Braine-l'Alleud€2.0m€0.1m
Movikor Kortrijk€1.9m€0.1m
Trypack Agro Houthulst€1.7m€0.1m
Munt40 Leuven€2.0m€0.1m
HENK FIEY Ieper€1.7m€0.1m
Full comparison

Key facts about DETOX PHARMA

What is the company number of DETOX PHARMA?
The company number of DETOX PHARMA is 0722.889.827. The VAT number is the same number with BE in front: BE 0722.889.827.
Where is DETOX PHARMA based?
The registered office is at Boulevard de l'Hôpital 61, 7800 Ath.Company details
What does DETOX PHARMA do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of DETOX PHARMA?
The legal form of DETOX PHARMA is Private limited company (BV).
When was DETOX PHARMA founded?
DETOX PHARMA was founded on 19-03-2019.
Is DETOX PHARMA still active?
Yes, DETOX PHARMA is an active enterprise in the KBO register.
Which joint committee does DETOX PHARMA fall under?
In its 2022 annual accounts, DETOX PHARMA states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of DETOX PHARMA?
The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €125,207 and 94 comparable companies (NACE 70200). It probably lies between €160,000 and €260,000.Financials
Is DETOX PHARMA profitable?
In financial year 2025, DETOX PHARMA made a profit of €152,406.
Where can I find the annual accounts of DETOX PHARMA?
DETOX PHARMA filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DETOX PHARMA due?
DETOX PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.